Clinical Trial Update: Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eicosapentaenoic acid for cerebral vasospasm following subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Subarachnoid Hemorrhage

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Yamaguchi University Hospital | Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 4 | Status: COMPLETED